Soma S Nag

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease
    Soma S Nag
    Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania, USA
    Am J Cardiol 95:862-4. 2005
  2. ncbi LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO
    Soma S Nag
    Merck and Co, Inc, 770 Broad Street, West Point, PA, USA
    J Manag Care Pharm 13:652-63. 2007
  3. ncbi Reassessment of cardiovascular risk in diabetes
    Jonathan R Jaffe
    Merck and Co, Inc, Sumneytown Pike, West Point, Pennsylvania 19486, USA
    Curr Opin Lipidol 17:644-52. 2006
  4. ncbi Trends in lipid management among patients with diabetes
    Kaan Tunceli
    Center for Health Services Research, Henry Ford Health System, Detroit, Michigan 48202, USA
    Endocr Pract 12:380-7. 2006

Detail Information

Publications4

  1. ncbi Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease
    Soma S Nag
    Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania, USA
    Am J Cardiol 95:862-4. 2005
    ..The overall lipid-lowering therapy treatment rate was 38% and the estimated lipid treatment gap (percent needing treatment who were not receiving it) was 62%...
  2. ncbi LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO
    Soma S Nag
    Merck and Co, Inc, 770 Broad Street, West Point, PA, USA
    J Manag Care Pharm 13:652-63. 2007
    ..Patients with coronary heart disease or diabetes are at high risk of coronary events and are particularly important target groups for monitoring and dose adjustment of lipid-modifying drug therapy...
  3. ncbi Reassessment of cardiovascular risk in diabetes
    Jonathan R Jaffe
    Merck and Co, Inc, Sumneytown Pike, West Point, Pennsylvania 19486, USA
    Curr Opin Lipidol 17:644-52. 2006
    ..SUMMARY: The majority of adults with diabetes have a substantially greater risk compared with those without diabetes and a small percentage has very high risk. A minority of individuals may have considerably lower 10-year risk...
  4. ncbi Trends in lipid management among patients with diabetes
    Kaan Tunceli
    Center for Health Services Research, Henry Ford Health System, Detroit, Michigan 48202, USA
    Endocr Pract 12:380-7. 2006
    ..Particular attention may be warranted to ensure that patients with diabetes receive lipid-lowering agents not only after a cardiovascular event but also before such an event occurs...